Outcomes From Treatment Liver and Bile Duct Diseases

Running, not enrolling

Conditions studied: Benign or Malignant Liver and Bile Duct Disease

In brief

It is reported in the literature that the treatment of any liver and bile duct disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with adenocarcinoma continue to be diagnosed at an advanced stage with medical and surgical options that are improving in terms of outcome measurements but with much more room for improvement. Our goal is to continue to review our treatment outcomes to further improve overall survival, overall symptom control, mortality and morbidity. The main aim of this study is to evaluate and compare the outcomes from our multiple treatments of benign or malignant liver and bile duct diseases.

Key facts

Study ID

NCT04637243

Run by

Methodist Health System

People needed

126

Starts

2023-03-09

Expected to finish

2026-12-31

Last updated by the study team

2026-06-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients diagnosed and treated for liver and bile duct disease benign or malignant from 2005 to present (up to the day before this study receives IRB approval)
• Age > 18 years

You may not qualify if…

• Patients that are not diagnosed with or treated for liver and bile duct disease
• Age < 18 years

Where it is running

• Methodist Richardson Medical Center — Richardson, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.